Sinopharm Group Co Ltd (X2S.DU)
| Previous close | 1.8740 |
| Open | 1.8895 |
| Bid | 1.9080 x N/A |
| Ask | 1.9670 x N/A |
| Day's range | 1.8890 - 1.8895 |
| 52-week range | 1.8140 - 2.7180 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 Oct 2024 - 29 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Top SEHK Dividend Stocks To Consider In September 2024
As global markets navigate a period of economic adjustments, the Hong Kong market has shown resilience amid broader fluctuations. With the European Central Bank cutting rates and anticipation of similar moves by the U.S. Federal Reserve, investors are keenly observing dividend stocks for their potential stability and income generation. In this context, selecting strong dividend stocks can provide a reliable income stream while potentially offering some cushion against market volatility.
Simply Wall St.Top Dividend Stocks On SEHK To Consider In August 2024
As global markets react to economic data and shifts in investor sentiment, the Hong Kong market has shown resilience amid broader uncertainties. With the Hang Seng Index experiencing modest declines, dividend stocks on the SEHK remain a compelling option for investors seeking stable returns in volatile times. In this environment, selecting dividend stocks with strong fundamentals and consistent payout histories can provide a reliable income stream and mitigate some of the risks associated...
- Simply Wall St.
Top Dividend Stocks In Hong Kong For June 2024
As global markets navigate through mixed economic signals, Hong Kong's market shows resilience, marked by a modest uptick in the Hang Seng Index and robust retail sales growth. In such an environment, dividend stocks in Hong Kong could offer investors a blend of stability and potential income amid prevailing uncertainties.
